VHL is a component of the E3 ubiquitin ligase that binds to hypoxia-inducible factor (HIF) leading to HIF degradation, and loss of VHL function in ccRCC results in HIFα activation which drives VEGF expression (Gnarra et al., 1996). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.